United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - pilocarpine nitrate - eye drops - 20mg/1ml

United States - English - NLM (National Library of Medicine)

rebel distributors corp - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - pilocarpine hydrochloride can be used in the medical management of glaucoma, especially open-angle glaucoma, in those cases in which the intraocular pressure can be controlled adequately by the topical administration of pilocarpine. in acute (closed-angle) glaucoma, pilocarpine hydrochloride may be used alone, or in combination with other cholinergic agents or carbonic anhydrase inhibitors, to relieve tension prior to emergency surgery. patients may be maintained on pilocarpine hydrochloride as long as intraocular pressure is controlled and there is no deterioration in the visual fields. the choice of concentration should be determined by the severity of the condition and the response of the patient. pilocarpine hydrochloride is also indicated to counter the effects of cycloplegics and mydriatics following surgery or ophthalmoscopic examination. parasympathomimetics are contraindicated where miosis is undesirable such as acute iritis or pupillary block glaucoma. this product is also contraindicated in persons

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - tropicamide, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; purified water - to produce mydriasis and cycloplegia.

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - tropicamide, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; purified water - to produce mydriasis and cycloplegia.

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 40 mg/ml; fluorescein sodium, quantity: 2.5 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid; povidone - as a diagnostic stain and topical anaesthetic combined, minims lignocaine and fluorescein is intended primarily to facilitate goldmann applanation tonometry.

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - cyclopentolate hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid - to produce mydriasis and cycloplegia

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - atropine sulfate monohydrate, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; purified water - to produce mydriasis and cycloplegia

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 3.42 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; sodium hydroxide - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; benzalkonium chloride; water for injections - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - tropicamide, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; benzalkonium chloride; purified water; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at 14 july 2003 : used to produce mydriasis and cycloplegia for diagnostic purposes.